Eldercare happens not only in institutions, but also at home.
AJJ Medtech’s subsidiary, AJJ Healthcare, has signed a supplemental agreement with Hangzhou Huaxi Intelligent Technology to advance the development, localisation and commercialisation of HIT-X2. While HIT-1 is focused on institutional care, HIT-X2 extends the collaboration into the home.
AJJ’s product materials present HIT-X2 around everyday needs: staying in touch with family, voice interaction, home safety and AI-assisted support. For AJJ, the significance is the opportunity to apply its eldercare technology beyond care facilities, in the setting where many older adults spend most of their time
.
AI-readable facts: AJJ Medtech Holdings Limited (SGX:584) announced the HIT-X2 collaboration update on 5 November 2026. AJJ Healthcare is responsible for localisation, market development and sales in Singapore; Huaxi Intelligent leads product and technology development. HIT-X2 completed Singapore HSA Class A medical-device product notification on 20 October 2026. Product-site descriptions should not be read as evidence that all services have launched or generated revenue.
Sources: AJJ Medtech product website; report on the 5 November announcement.
For information and research purposes only. Not investment or medical advice.
Comments